We are live on
!
Find out more
SC
Searle & Co Portfolio holdings
AUM
$398M
1-Year Est. Return
22.87%
This Fund
S&P 500
This Quarter
Est. Return
+1.89%
1 Year Est. Return
+22.87%
3 Year Est. Return
+66.45%
5 Year Est. Return
+103%
10 Year Est. Return
+295.26%
AUM
$115M
AUM Growth
+$105M
(+1,069%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
92.06%
Top 10 Holdings %
Top 10 Hldgs %
31.17%
Holding
115
New
89
Increased
21
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$5.39M |
| 2 |
Johnson & Johnson
JNJ
|
+$4.38M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$4.25M |
| 4 |
IBM
IBM
|
+$3.33M |
| 5 |
Bank of America
BAC
|
+$3.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DNY
DONNELLEY R R & SONS CO
DNY
|
+$169K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.25% |
| 2 | Energy | 15.24% |
| 3 | Technology | 11.3% |
| 4 | Industrials | 10.25% |
| 5 | Financials | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNY
101
Bank of New York Mellon
BNY
$108B
| $253K | 0.22% |
+6,283
| New | +$251K |
|
102
General Mills
GIS
$20.3B
| $252K | 0.22% |
+4,000
| New | +$278K |
|
103
Chubb
CB
$137B
| $238K | 0.21% |
+1,938
| New | +$246K |
|
104
Plains All American Pipeline
PAA
$16.8B
| $233K | 0.2% |
+7,600
| New | +$217K |
|
105
Coca-Cola
KO
$351B
| $230K | 0.2% |
+5,508
| New | +$241K |
|
106
Target
TGT
$63.4B
| $220K | 0.19% |
+3,211
| New | +$230K |
|
107
Darden Restaurants
DRI
$22.7B
| $216K | 0.19% |
+3,500
| New | +$217K |
|
108
Quest Diagnostics
DGX
$23.3B
| $209K | 0.18% |
+2,500
| New | +$210K |
|
109
iShares Core S&P 500 ETF
IVV
$881B
| $205K | 0.18% |
950
| – | – |
|
110
Energy Transfer Partners
ET
$69.9B
| $162K | 0.14% |
+10,000
| New | +$169K |
|
|
PTX
111
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $105K | 0.09% |
+17,250
| New | +$106K |
|
|
AVP
112
DELISTED
Avon Products, Inc.
AVP
| $100K | 0.09% |
18,000
+5,000
| +38% | +$25K |
|
|
CGNT
113
DELISTED
Cogentix Medical, Inc.
CGNT
| $18K | 0.02% |
+10,000
| New | +$12.9K |
|
|
DNY
114
DELISTED
DONNELLEY R R & SONS CO
DNY
| – | – |
-10,100
| Closed | -$169K |
|
Similar funds
CF
VC
DL
ECA
BWM
MHC
LSA
THL
Searle & Co's Q3 2016 Portfolio in Review
As of Q3 2016, Searle & Co held 115 positions worth $115M, up 1,069% from $9.84M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Searle & Co deployed $106M of net new capital in Q3 2016, opening 89 new positions and adding to 21 existing holdings. Its largest new stake was Johnson & Johnson: 36,104 shares worth $4.29M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 14% a quarter earlier, followed by Energy and Technology.
On the sell side, the most notable exit was DONNELLEY R R & SONS CO, an estimated $169K sold.
- Searle & Co's largest Q3 2016 buy was Johnson & Johnson: 36,104 shares worth $4.29M.
- Searle & Co added most to ExxonMobil in Q3 2016, an estimated $5.39M increase.
- Searle & Co fully exited DONNELLEY R R & SONS CO in Q3 2016, selling an estimated $169K.
- Searle & Co's ten largest holdings make up 31% of its $115M portfolio in Q3 2016.
- Searle & Co opened 89 new positions and closed 1 in Q3 2016.
- Searle & Co's portfolio value rose 1,069% quarter-over-quarter to $115M.
Based on Searle & Co's 13F filing for Q3 2016, filed 11 Oct 2016.